Cargando…
Reducing excitoxicity with glutamate transporter-1 to treat stroke
The neurotransmitter glutamate is released following ischemic brain damage, and its excitotoxic effects contribute greatly to the development of stroke. Because this release of glutamate occurs within minutes, therapeutic drugs targeting the restriction of glutamate-induced excitotoxicity must be ad...
Autores principales: | Wang, Yun, Harvey, Brandon K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126272/ https://www.ncbi.nlm.nih.gov/pubmed/30276285 http://dx.doi.org/10.4103/2394-8108.192523 |
Ejemplares similares
-
Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke
por: Campos, Francisco, et al.
Publicado: (2012) -
Creatine Protects against Excitoxicity in an In Vitro Model of Neurodegeneration
por: Genius, Just, et al.
Publicado: (2012) -
Targeted Over-Expression of Glutamate Transporter 1 (GLT-1) Reduces Ischemic Brain Injury in a Rat Model of Stroke
por: Harvey, Brandon K., et al.
Publicado: (2011) -
AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity
por: Guggenhuber, Stephan, et al.
Publicado: (2010) -
Anti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain
por: Lee, Hye-Kyung, et al.
Publicado: (2017)